These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

80 related articles for article (PubMed ID: 5434039)

  • 21. [Instrument for restoring damaged lacrimal ducts].
    Kiselev GA; Lebedev OI
    Oftalmol Zh; 1986; (5):318. PubMed ID: 3785847
    [No Abstract]   [Full Text] [Related]  

  • 22. A useful alternative to silicone intubation in congenital nasolacrimal duct obstructions.
    Havins WE; Wilkins RB
    Ophthalmic Surg; 1983 Aug; 14(8):666-70. PubMed ID: 6622008
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [On cysts of the tear gland].
    Radnót M
    Klin Monbl Augenheilkd; 1965 Dec; 147(5):742-5. PubMed ID: 5869309
    [No Abstract]   [Full Text] [Related]  

  • 24. [Treatment of congenital obstruction of lacrimal passage in the newborn].
    Filipowicz-Banachowa A
    Klin Oczna; 1974 Jul; 44(7):693-7. PubMed ID: 4845193
    [No Abstract]   [Full Text] [Related]  

  • 25. Results of endoscopic assisted probing for congenital nasolacrimal duct obstruction in older children.
    Kouri AS; Tsakanikos M; Linardos E; Nikolaidou G; Psarommatis I
    Int J Pediatr Otorhinolaryngol; 2008 Jun; 72(6):891-6. PubMed ID: 18440076
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Evaluation and management of congenital nasolacrimal duct obstruction.
    Kapadia MK; Freitag SK; Woog JJ
    Otolaryngol Clin North Am; 2006 Oct; 39(5):959-77, vii. PubMed ID: 16982257
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Congenital nasolacrimal duct obstruction in Kayseri, Turkey.
    Ekinciler OF; Doğan H; Tatlişen N; Karaküçük S
    Turk J Pediatr; 1994; 36(1):21-33. PubMed ID: 8191605
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Congenital dacryocystocele: five clinical cases.
    Hupin C; Lévèque N; Eloy P; Bertrand B; Rombaux P
    B-ENT; 2008; 4(3):141-5. PubMed ID: 18949960
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Treatment of congenital dacryostenosis.
    Neetens A; Rubbens MC
    Bull Soc Belge Ophtalmol; 1980; 191():5-11. PubMed ID: 7343031
    [No Abstract]   [Full Text] [Related]  

  • 30. [The place of bicanaliculonasal intubation in the treatment of congenital dacryostenosis].
    Lemoine JJ; Le Rebeller MJ; Boulais G
    Bull Mem Soc Fr Ophtalmol; 1982; 94():67-71. PubMed ID: 7184597
    [No Abstract]   [Full Text] [Related]  

  • 31. A rare solitary fibrous tumour of the lacrimal sac presenting as acquired nasolacrimal duct obstruction.
    Rumelt S; Kassif Y; Cohen I; Rehany U
    Eye (Lond); 2003 Apr; 17(3):429-31. PubMed ID: 12724712
    [No Abstract]   [Full Text] [Related]  

  • 32. [Lacrimal duct obstruction and its treatment. II. The most frequent pathological pictures causing lacrimal obstruction and their treatment].
    Anders M
    Cesk Oftalmol; 1980 May; 36(3):202-9. PubMed ID: 7397854
    [No Abstract]   [Full Text] [Related]  

  • 33. [Lacrimal duct probing in young children with a congenital lacrimal duct obstruction at the Utrecht University Medical Center: generally an effective treatment].
    van Velthoven ME; Wittebol-Post D; Berendschot TT; Mourits MP
    Ned Tijdschr Geneeskd; 2003 Apr; 147(16):764-8. PubMed ID: 12731469
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Treatment of non-traumatic obstructions of the lacrimal canal by permanent nasolacrimal drains (author's transl)].
    Lemagne JM
    J Fr Ophtalmol; 1981; 4(8-9):575-7. PubMed ID: 7320408
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Changes of conjunctiva and tear ducts in long-term use of neoeserine].
    Kühl W; Haubenreiser L
    Dtsch Gesundheitsw; 1971 Oct; 26(41):1953-8. PubMed ID: 5003819
    [No Abstract]   [Full Text] [Related]  

  • 36. Incontinentia pigmenti associated with nasolacrimal duct obstruction.
    Smith B; Bedrossian EH
    Ophthalmic Surg; 1984 Dec; 15(12):980-2. PubMed ID: 6521980
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Progress in the treatment for nasolacrimal duct obstruction].
    Zhang Q; Qian Y
    Zhonghua Zheng Xing Wai Ke Za Zhi; 2000 Mar; 16(2):108-9. PubMed ID: 11593619
    [No Abstract]   [Full Text] [Related]  

  • 38. [Treatment of congenital dacryostenosis].
    Neetens A; Rubbens MC
    Bull Mem Soc Fr Ophtalmol; 1982; 94():48-50. PubMed ID: 6307443
    [No Abstract]   [Full Text] [Related]  

  • 39. [The significance of maxillary sinusitis for the development of dacryostenosis].
    Müller W; Köhler U; Rose KG
    Klin Monbl Augenheilkd; 1968; 153(5):660-2. PubMed ID: 5710548
    [No Abstract]   [Full Text] [Related]  

  • 40. [Lacrimal duct obstruction and its treatment. I. Recent views of the anatomy and physiology of the lacrimal ducts and a review of examinations for their patency and functional fitness].
    Anders M
    Cesk Oftalmol; 1980 May; 36(3):195-201. PubMed ID: 7397853
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.